AI platform (ELISE) streamlining medical writing.
| Date | Round | Amount |
|---|---|---|
| Nov 2024 | Seed Paris-based Biolevate raised 6M EUR seed led by EQT Ventures to refine its AI medical-writing platform ELISE. | $6.3M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.